| Filed On | Filing |
|---|---|
| 23 Jan 2025 |
Form 4/A: Halligan Brian, Director
Received 7,125 shares by exercise or conversion ($376K) · Sold 8,500 shares ($6.03M) |
| 19 Aug 2024 |
Form 4/A: Johnson Claire D'Oyly-Hughes, Director
Granted 204 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Gill Ronald S, Director
Granted 679 Stock Option (right to buy) · Granted 242 Stock Option (right to buy) · Granted 204 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Rangan Yamini, Director
Granted 10,405 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Caldwell Nick V., Director
Granted 242 Stock Option (right to buy) · Granted 204 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Shah Dharmesh, Director
Granted 6,274 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Halligan Brian, Director
Granted 13,656 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Ward Jill A, Director
Granted 679 Stock Option (right to buy) · Granted 242 Stock Option (right to buy) · Granted 204 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Simons Jay, Director
Granted 679 Stock Option (right to buy) · Granted 242 Stock Option (right to buy) · Granted 204 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Norrington Lorrie M, Director
Granted 242 Stock Option (right to buy) · Granted 204 Stock Option (right to buy) |
| 19 Aug 2024 |
Form 4/A: Bueker Kathryn, Chief Financial Officer
Granted 10,215 Stock Option (right to buy) |
Loading...
